RecruitingNCT06565936

DPA-714 and FDG PET/MRI in Depression

This recruiting study focuses on depression and currently lists sites or participation links in China.

DepressionOtherFrom 35 Years to 85 Years

In plain English

Key information made simple

This study exists to compare options and see whether the medication DPA-714 offers something meaningfully different. Researchers are trying to understand whether the medication DPA-714 can improve attention, thinking, or day-to-day functioning. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including The First Affiliated Hospital of Dalian Medical University in Dalian. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent and matching the main diagnosis. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06565936. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in China.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com